(21) reported that tremelimumab [a Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) inhibitor] combined with radiofrequency ablation, a potential novel treatment for advanced HCC, led to an accumulation of intratumoral CD8+ T cells. The gene discussed is CTLA4; the disease is hepatocellular carcinoma.